Elutia Inc. (ELUT) - Year-over-year earnings per share growth for the last twelve months

Brandmark of Elutia Corp (ELUT)

Elutia Inc. (ELUT) controls complex bioprocesses within its laboratories, delegating only the packaging. The quarterly EPS growth assessment demonstrates a margin recovery trend, where 22.70 determines the current value of the metric. The company's potential relies on unique antibiotic matrices and the creation of a safe implant system that minimizes the risk of tissue rejection in surgery.

ELUT: Elutia Year-over-year earnings per share growth rate for the last twelve months 02/21/2024 - 11/14/2026

ELUT (elutia.com): analytical breakdowns and indicator data

- market value and analyst target forecast:
Price Chart Elutia Inc.|ELUT - Broker Consensus Forecast
- market capitalization indicators:
Market Value Elutia Inc|ELUT - Company Buyout Price
- book capitalization data:
Accounting Value per Share Elutia|ELUT - Total Net Assets|Market Value to Book Value Ratio elutia.com|ELUT - Aggregate Asset Value
- debt level and financial liquidity data:
Total Debt to Equity Ratio Elutia Inc.|ELUT - Long-Term Debt to Capital|Short-Term Debt to Equity Elutia Inc|ELUT - Company Total Debt|Debts to Book Capitalization Elutia Corp|ELUT - Long-Term Debt|Company Short-Term Debt Elutia|Quick Liquidity Indicator elutia.com
- earnings and valuation multiples information:
ELUT - Profit After Payment of Taxes|Expected Profit Elutia Inc.|ELUT - Business Payback Period|Forward P/E Multiple Elutia Inc|ELUT - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Elutia|ELUT - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Elutia|ELUT - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months elutia.com|ELUT - Net earnings per one share growth for the current year|Earnings growth forecast for next year Elutia Inc.
- sales and revenue indicators:
ELUT - Company Gross Revenue|Projected Sales Volume Elutia Inc|ELUT - P/S Multiple|Forward Price-to-Revenue Multiple Elutia Inc.
Basic company analysis:elutia.com - ELUT
Finished products of Elutia Inc.

This indicator measures the rate of change in earnings per share, reflecting the balance between operating income and expenses to assess the fundamental efficiency of the business. For Elutia Inc. (ELUT), the trend of this parameter confirms the successful commercial implementation of EluPRO shells and the expansion of insurance coverage, which is clearly demonstrated by the quarterly increase in EPS through the lens of margin growth.

Analysis of competing companies

Intuitive Surgical (ISRG) - Year-over-year earnings per share growth for the last twelve months|DHR - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BDX|STE (steris.com) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months West Pharmaceutical Services, Inc. (WST)|BAX (Baxter Corp) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Masimo Personal Health MASI|Year-over-year earnings per one share growth for the last 12 months STVN|TFX - Year-over-year earnings per share growth for the last twelve months|MMSI - Quarterly EPS earnings growth|Envista Holdings Corporation (NVST) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months ICU Medical|XRAY (dentsplysirona.com) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months LeMaitre Corp LMAT|Year-over-year earnings per share growth for the last twelve months AtriCure (ATRC)|STAAR Surgical - Year-over-year earnings per share growth for the last 12 months|Chromadex Corp - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ZIMV (ZimVie Inc)|ANGO - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Cerus Corp CERS|TKNO: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months monogramorthopedics.com|STSS (sharpstechnology.com) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months INFU (InfuSystem Holdings)|Quarterly EPS earnings growth UTMD|KRMD (KORU Medical Systems Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Nyxoah SA NYXH|Year-over-year earnings per one share growth for the last 12 months MBOT|Pro-Dex Corp - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Zentek Ltd|MLSS (Milestone Scientific Inc.) - Year-over-year net earnings per share growth for the last 12 months|NXGL (NEXGEL, Inc.) - Year-over-year earnings per share growth for the last twelve months|RVP (Retractable Tech) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months HBIO (Harvard Bioscience, Inc.)|Year-over-year net earnings per share growth for the last 12 months FEMY (Femasys)|MHUA - Earnings per share growth in annualized terms for the last twelve months|Predictive Oncology Corp - Year-over-year net earnings per share growth for the last 12 months|CJMB - Year-over-year net earnings per share growth for the last 12 months|ATRI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months NeuroMetrix NURO